However, Jing Wang evaluated the impacts of treatment with inhaled interferon-γ (IFN-γ) in idiopathic pulmonary fibrosis (IPF) on LRT microbiome and host immune phenotype [54]. Here, IFNG is linked to pulmonary fibrosis.